Donate

Latest news & articles

Latest news
Advocacy Spotlight: Meet Rebecca & Nikolas
Advocacy

Advocacy Spotlight: Meet Rebecca & Nikolas

Nikolas Mirco is 12-year-old West Australian who has been living with type 1 diabetes (T1D) since he was seven years old. He and his mum, Rebecca, joined JDRF Australia’s advocacy program this year, to raise the profile of T1D and advocate for increased research funding for the JDRF Clinical Research Network (CRN). Nikolas and Rebecca […]
Funding to characterise a new target for type 1 diabetes prevention
Research

Funding to characterise a new target for type 1 diabetes prevention

JDRF is proud to announce new funding of $200,000 (USD) to Dr Irina Buckle from Mater Research and The University of Queensland, to undertake a project which aims to understand what may be driving type 1 diabetes.   Type 1 Diabetes (T1D) is a condition where certain types of immune cells, known as T cells, incorrectly […]
New formulation of insulin may speed up its action for people with type 1 diabetes
Research

New formulation of insulin may speed up its action for people with type 1 diabetes

A research group from Norway has found that adding small amounts of glucagon to insulin speeds up its action. For people with type 1 diabetes (T1D) this would mean a faster acting insulin than what is on the market, and in turn, improved quality of life.    The need for fast insulin T1D is an autoimmune […]
Advocacy Spotlight: Meet Giselle
Advocacy

Advocacy Spotlight: Meet Giselle

Earlier this month, our advocates and the JDRF team were in Parliament House for the exciting research announcement regarding funding committed for five research projects in collaboration with the ENDIA study. In addition to this they were able to meet with key decision makers and discuss the reality of type 1 diabetes (T1D) along with the importance […]
New support for Australia’s best and brightest early career researchers
Research

New support for Australia’s best and brightest early career researchers

JDRF is delighted to announce that three Australian Early to Mid-Career Researchers (EMCRs) are being supported with over $2.2 million to continue their groundbreaking type 1 diabetes (T1D) research.   JDRF is committed to nurturing the growth and impact of leading independent researchers who are instrumental in translating scientific discoveries to clinical applications.  Dr Aveni Haynes […]
JDRF supports a medical corridor in the Middle East
Research

JDRF supports a medical corridor in the Middle East

JDRF, the leading global type 1 diabetes (T1D) research and advocacy organisation, joins healthcare and humanitarian non-profits throughout the world in calling for a medical corridor to allow immediate access to lifesaving supplies and medicines, like insulin, needed by all people living with T1D in the Middle East conflict zone. At all times, including times […]
$3 million invested to understand and prevent the development of T1D
Research

$3 million invested to understand and prevent the development of T1D

JDRF Australia and The Leona M. and Harry B. Helmsley Charitable Trust (Helmsley) have committed $3 million for research projects aimed at understanding how type 1 diabetes (T1D) develops, with the ultimate goal of preventing it. This is in collaboration with the Environmental Determinants of Islet Autoimmunity (ENDIA) Study. ENDIA is the world’s first T1D observational […]
Type 1 diabetes research breakthrough shows insulin-producing cells can be regenerated
Research

Type 1 diabetes research breakthrough shows insulin-producing cells can be regenerated

We could be one step closer to replacing the need for regular insulin injections in people living with type 1 diabetes (T1D), thanks to JDRF-funded Australian research that was published this week in the prestigious Nature journal. Why is this research important? During T1D development, the immune system mistakenly attacks the insulin-producing beta cells in […]
World-first Australian clinical trial shows promise for suppressing progression of type 1 diabetes in those newly diagnosed
Research

World-first Australian clinical trial shows promise for suppressing progression of type 1 diabetes in those newly diagnosed

  A JDRF-funded, world-first clinical trial has shown that a commonly prescribed rheumatoid arthritis drug (baricitinib) can preserve the body’s own insulin production and suppress the progression of type 1 diabetes (T1D) in those newly diagnosed with the condition. This comes after three decades of research out of the St Vincent’s Institute (SVI) in Melbourne, […]
New research funding may allow those with type 1 diabetes to make insulin again
Research

New research funding may allow those with type 1 diabetes to make insulin again

JDRF has just funded a new Australian islet transplantation research project with the potential to revert type 1 diabetes. The benefits of islet transplantation Pancreatic islet transplantation is a life-saving and life-changing treatment currently available for people with type 1 diabetes (T1D) who are unaware of their dangerously low blood glucose levels (known as ‘severe […]
Regenerating damaged beta cells in type 1 diabetes: new funding announced
Research

Regenerating damaged beta cells in type 1 diabetes: new funding announced

JDRF has funded a new Australian research project which may allow those with type 1 diabetes (T1D) to regenerate lost pancreatic cells. During T1D development, the immune system mistakenly attacks the insulin-producing beta cells in the pancreas. This leads to the loss and destruction of beta cells, meaning that people with T1D are no longer […]
Research breakthrough shows that antivirals can delay T1D progression
Research

Research breakthrough shows that antivirals can delay T1D progression

A new study suggests that giving antivirals shortly after a type 1 diabetes (T1D) diagnosis may preserve the body’s ability to produce insulin. Recent results from a clinical trial published in the prestigious Nature journal have suggested that administering the antivirals pleconaril and ribavirin can preserve beta cell function in children and teenagers recently diagnosed […]
Type 1 diabetes screening pilot rolls out in primary school for the first time
Research

Type 1 diabetes screening pilot rolls out in primary school for the first time

This World Diabetes Day, on Tuesday 14th November, students from kindergarten and year 4 at Inaburra School in Sydney’s south participated in screening to detect type 1 diabetes (T1D). This is part of the JDRF-funded Australian Type 1 Diabetes National Screening Pilot, a research project looking to identify early-stage T1D in childhood. It was the first […]
Teplizumab shown to slow down type 1 diabetes in those newly diagnosed
Research

Teplizumab shown to slow down type 1 diabetes in those newly diagnosed

Research findings have just been released for the PROTECT clinical trial which tested whether the disease-modifying therapy Teplizumab is able to delay type 1 diabetes (T1D) progression in those newly diagnosed. What is Teplizumab?  Teplizumab is a therapy which has been shown to delay the progression from an early stage of T1D (Stage 2) to […]
Talking with David de George, PhD researcher and Career Support and Travel Grant Recipient
Research

Talking with David de George, PhD researcher and Career Support and Travel Grant Recipient

JDRF Australia’s Career Support and Travel Grants for domestic and international travel are designed to support the next generation of type 1 diabetes (T1D) researchers. They allow early to mid-career researchers and allied health professionals to gain new skills, exchange knowledge, and establish connections and collaborations. We recently spoke to David de George, PhD student […]
JDRF Australia and DrimTel announce new partnership
News

JDRF Australia and DrimTel announce new partnership

JDRF Australia and newly launched telco provider, DrimTel, have announced they are partnering in a move that will support type 1 diabetes (T1D) research breakthroughs while providing the community with technological solutions. DrimTel, which offers Mobile SIM Only, Data Only, and nbn® Plans for residential and business customers, was founded by Ljupco (Lj) Taneski after […]
Innovate in the world of type 1 diabetes: join the Commercialisation Essentials Workshop
Research

Innovate in the world of type 1 diabetes: join the Commercialisation Essentials Workshop

Are you passionate about creating a world where research breakthroughs in type 1 diabetes (T1D) are rapidly turned into tangible treatments; a world where the most promising discoveries don’t just remain in labs but make their way swiftly to those who need them the most? Do you have a pioneering research project, innovative idea, or […]
New clinical trial looking for newly diagnosed children and young adults with T1D
Research

New clinical trial looking for newly diagnosed children and young adults with T1D

In people newly diagnosed with type 1 diabetes (T1D) there is often a ‘honeymoon’ phase where some pancreatic beta cells are still able to produce insulin. Committed to improving the lives of those with T1D, JDRF has invested in several clinical studies under the Australasian Type 1 Diabetes Immunotherapy Collaborative (ATIC),  investigating whether we can […]